Taking a cue from the human body’s own coagulation processes, researchers at UC Santa Barbara synthesize platelet-like nanoparticles that can do more than clot blood
Stanching the free flow of blood from an injury remains a holy grail of clinical medicine. Controlling blood flow is a primary concern and first line of defense for patients and medical staff in many situations, from traumatic injury to illness to surgery. If control is not established within the first few minutes of a hemorrhage, further treatment and healing are impossible.
At UC Santa Barbara, researchers in the Department of Chemical Engineering and at Center for Bioengineering (CBE) have turned to the human body’s own mechanisms for inspiration in dealing with the necessary and complicated process of coagulation. By creating nanoparticles that mimic the shape, flexibility and surface biology of the body’s own platelets, they are able to accelerate natural healing processes while opening the door to therapies and treatments that can be customized to specific patient needs.
“This is a significant milestone in the development of synthetic platelets, as well as in targeted drug delivery,” said Samir Mitragotri, CBE director, who specializes in targeted therapy technologies. Results of the researchers’ findings appear in the current issue of the journal ACS Nano.
The process of coagulation is familiar to anyone who has suffered even the most minor of injuries, such as a scrape or paper cut. Blood rushes to the site of the injury, and within minutes the flow stops as a plug forms at the site. The tissue beneath and around the plug works to knit itself back together and eventually the plug disappears.
But what we don’t see is the coagulation cascade, the series of signals and other factors that promote the clotting of blood and enable the transition between a free-flowing fluid at the site and a viscous substance that brings healing factors to the injury. Coagulation is actually a choreography of various substances, among the most important of which are platelets, the blood component that accumulates at the site of the wound to form the initial plug.
“While these platelets flow in our blood, they’re relatively inert,” said graduate student researcher Aaron Anselmo, lead author of the paper. As soon as an injury occurs, however, the platelets, because of the physics of their shape and their response to chemical stimuli, move from the main flow to the side of the blood vessel wall and congregate, binding to the site of the injury and to each other. As they do so, the platelets release chemicals that “call” other platelets to the site, eventually plugging the wound.
But what happens when the injury is too severe, or the patient is on anti-coagulation medication, or is otherwise impaired in his or her ability to form a clot, even for a modest or minor injury?
The Latest on: Bleeding control
via Google News
The Latest on: Bleeding control
- New Results on Blood Disorder Treatments Are Coming. Watch These Stocks.on December 4, 2020 at 5:03 am
It sought approval from the U.S. Food and Drug Administration for its Roctavian treatment, after a Phase 3 clinical trial showed dramatic control of bleeding in treated patients. But the FDA demurred ...
- Mother, 42, reveals car crash left her battling an antibiotic-resistant infectionon December 4, 2020 at 3:15 am
A mother-of-two has revealed how a car crash left her battling an antibiotic-resistant infection. Vanessa Carter, 42, from Johannesburg, South Africa, was a passenger when the vehicle spun out of ...
- Did a Clinical Trial Participant Develop ‘Huge Bleeding Sores’ From a COVID-19 Vaccine?on December 3, 2020 at 2:30 pm
The claim, which has spread across the anti-vaccine internet zeitgeist without context, stems from a GoFundMe page whose organizer has since walked back her claims.
- Octapharma presents research on congenital & acquired bleeding disorders at ASH Meetingon December 2, 2020 at 9:04 pm
Octapharma USA will present multiple clinical research posters focused on the efficacy and safety of fibryga®, Fibrinogen (Human) Lyophilized Powder for Reconstitution, for Intravenous Use in the ...
- Bleeding the Leechon December 2, 2020 at 9:25 am
During the chat, we want to get information about the Leech from him. We can threaten him, convince him to reveal the information we want (Charsma Lv 2) or take your chances and tell him you are with ...
- Why you should teach bleeding control for bystanderson December 2, 2020 at 7:53 am
Like CPR, packing a wound takes skill, and a new no-fuss trainer makes it easy for anyone to learn proper bleeding control techniques ...
- Octapharma USA Presents Bleeding Disorders Research at Virtual ASH Annual Meetingon December 1, 2020 at 10:03 am
Octapharma USA will present its most recent rare bleeding disorders research during the American Society of Hematology Annual Meeting, Dec. 5 - 8.
- Five-year-old girl raped, bitten and left bleeding in Andhra Pradesh's Kakinadaon November 26, 2020 at 2:58 am
A five-year-old girl was allegedly raped and left in critical condition under a tree near her house in Andhra Pradesh's Kakinada.
- CAPEX & Spending Cuts Across Industries Leaves the Cold Insulation Market Bleeding $854 Million in Losseson November 25, 2020 at 9:28 am
The global market for Cold Insulation is expected to slump by -18.7%in the year 2020 and thereafter recover to reach a projected US$5.4 billion by the year 2027, trailing a post COVID-19 CAGR of 5.7% ...
- Chinese women with mandatory birth control coils find little recourseon November 20, 2020 at 8:35 am
When the two coils that had spent close to two decades in her body were removed, Lu Ying (a pseudonym) said she felt reborn. Lu, from Pujiang county in East China's Zhejiang province, had the first of ...
via Bing News